Press release: DiaSys introduces dedicated respons® and BioMajesty® JCA-BM6010/C kits for Procalcitonin FS

After two years of successful marketing of Procalcitonin FS, dedicated kits are now available for the DiaSys respons® systems and BioMajesty® JCA-BM6010/C. Procalcitonin FS offers a reliable alternative, when time matters in sepsis management.

Procalcitonin FS is a particle enhanced immunoturbidimetric assay for the determination of procalcitonin (PCT) in serum and plasma on automated photometric systems. PCT is a sensitive marker for bacterial infections and sepsis, which is a life-threatening organ dysfunction caused by a dysregulated host immune response to infection. It is a global health concern and a leading cause of death in hospitals worldwide, affecting an estimate of 48.9 million people each year.

The DiaSys assay offers high precision at clinical cut-off levels and a measuring range from 0.27 ng/mL (LoD depending on the analyzer) to 50 ng/mL. No prozone effect is observed up to 1000 ng/mL. Furthermore, Procalcitonin FS has good onboard and calibration stability and shows high tolerance to endogenous interferents and common therapeutics used in sepsis management. Additionally, the assay shows good concordance to established methods. In conclusion, DiaSys offers a reliable alternative, when time matters in sepsis management.

The new dedicated kits are provided with CE marked applications for respons®920, respons®940 and BioMajesty® JCA-BM6010/C. The respons® kit offers 120 tests per kit, the BioMajesty® JCA-BM6010/C kit 320 (2 x 160) tests per kit.

For more information, visit: https://www.diasys-diagnostics.com/products/reagents/immunoturbidimetry/reagent-details/227-procalcitonin-fs/reagent.show

DiaSys Diagnostic Systems GmbH · Alte Strasse 9 · 65558 Holzheim · Germany
www.diasys-diagnostics.com · info@diasys.de